Guardant Health (GH) Competitors $41.42 +0.44 (+1.07%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$42.38 +0.95 (+2.31%) As of 08/1/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GH vs. VCYT, NTRA, FMS, HIMS, OPCH, RDNT, BTSG, SHC, SGRY, and CONShould you be buying Guardant Health stock or one of its competitors? The main competitors of Guardant Health include Veracyte (VCYT), Natera (NTRA), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. Guardant Health vs. Its Competitors Veracyte Natera Fresenius Medical Care AG & Co. KGaA Hims & Hers Health Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Concentra Group Holdings Parent Veracyte (NASDAQ:VCYT) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk. Is VCYT or GH more profitable? Veracyte has a net margin of 7.13% compared to Guardant Health's net margin of -49.93%. Veracyte's return on equity of 6.14% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Veracyte7.13% 6.14% 5.60% Guardant Health -49.93%N/A -28.95% Which has more volatility and risk, VCYT or GH? Veracyte has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Do analysts rate VCYT or GH? Veracyte currently has a consensus target price of $40.90, indicating a potential upside of 73.01%. Guardant Health has a consensus target price of $54.95, indicating a potential upside of 32.66%. Given Veracyte's higher probable upside, equities research analysts plainly believe Veracyte is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veracyte 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70Guardant Health 0 Sell rating(s) 0 Hold rating(s) 19 Buy rating(s) 1 Strong Buy rating(s) 3.05 Which has higher valuation and earnings, VCYT or GH? Veracyte has higher earnings, but lower revenue than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeracyte$445.76M4.15$24.14M$0.4157.66Guardant Health$739.02M6.99-$436.37M-$3.35-12.36 Does the media favor VCYT or GH? In the previous week, Guardant Health had 14 more articles in the media than Veracyte. MarketBeat recorded 25 mentions for Guardant Health and 11 mentions for Veracyte. Veracyte's average media sentiment score of 1.31 beat Guardant Health's score of 0.96 indicating that Veracyte is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 9 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 10 Very Positive mention(s) 2 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in VCYT or GH? 92.6% of Guardant Health shares are held by institutional investors. 1.4% of Veracyte shares are held by company insiders. Comparatively, 6.1% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryVeracyte beats Guardant Health on 9 of the 17 factors compared between the two stocks. Get Guardant Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GH vs. The Competition Export to ExcelMetricGuardant HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.11B$3.00B$5.48B$9.51BDividend YieldN/A2.43%4.73%4.09%P/E Ratio-12.3617.6228.6723.80Price / Sales6.99179.18373.9066.58Price / CashN/A41.9535.4557.96Price / Book-16.918.508.275.55Net Income-$436.37M-$55.06M$3.24B$259.03M7 Day Performance-6.75%-3.98%-3.69%-4.59%1 Month Performance-17.46%9.59%4.33%4.46%1 Year Performance30.46%6.72%25.95%18.03% Guardant Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GHGuardant Health4.5808 of 5 stars$41.42+1.1%$54.95+32.7%+24.2%$5.11B$739.02M-12.362,021Trending NewsEarnings ReportAnalyst ForecastVCYTVeracyte2.8967 of 5 stars$25.02-0.9%$40.90+63.5%+3.0%$1.96B$463.39M61.03790Positive NewsUpcoming EarningsHigh Trading VolumeNTRANatera3.6987 of 5 stars$138.00-0.6%$183.76+33.2%+30.7%$18.84B$1.70B-93.884,434Trending NewsUpcoming EarningsInsider TradeFMSFresenius Medical Care AG & Co. KGaA3.5246 of 5 stars$25.86-2.2%$27.80+7.5%+33.8%$15.18B$19.49B23.091,384Positive NewsHIMSHims & Hers Health2.5708 of 5 stars$58.67+1.8%$39.83-32.1%+237.9%$13.13B$1.48B85.031,637Trending NewsUpcoming EarningsInsider TradeGap DownOPCHOption Care Health4.6326 of 5 stars$29.77+0.3%$35.50+19.2%-8.2%$4.87B$5.00B24.018,088News CoveragePositive NewsEarnings ReportAnalyst ForecastRDNTRadNet4.0831 of 5 stars$57.83+0.7%$69.60+20.4%-5.7%$4.34B$1.83B-134.4911,021Positive NewsBTSGBrightSpring Health Services2.7351 of 5 stars$20.48-0.2%$24.90+21.6%+60.6%$3.60B$11.27B73.1435,000News CoverageEarnings ReportGap DownSHCSotera Health2.4421 of 5 stars$12.29-0.1%$16.00+30.2%-18.2%$3.49B$1.10B153.643,000Upcoming EarningsSGRYSurgery Partners2.9411 of 5 stars$22.44+5.6%$33.33+48.5%-29.6%$2.88B$3.17B-14.6715,000Positive NewsUpcoming EarningsGap UpCONConcentra Group Holdings Parent2.8669 of 5 stars$20.05+2.0%$28.50+42.1%-14.0%$2.57B$1.93B14.9611,250Positive NewsUpcoming Earnings Related Companies and Tools Related Companies Veracyte Alternatives Natera Alternatives Fresenius Medical Care AG & Co. KGaA Alternatives Hims & Hers Health Alternatives Option Care Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GH) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardant Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
